| 期刊論文| 1. | 侯佩君、杜素豪、廖培珊、洪永泰、章英華(20080400)。臺灣鄉鎮市區類型之研究：「臺灣社會變遷基本調查」第五期計畫之抽樣分層效果分析。調查研究：方法與應用，23，7-32。 延伸查詢 | | 2. | Schoch-Spana, M.、Brunson, E. K.、Long, R.(2021)。The public's role in COVID-19 vaccination: humancentered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States。Vaccine，39，6004-6012。  | | 3. | Dubé, Eve、Laberge, Caroline、Guay, Maryse、Bramadat, Paul、Roy, Réal、Bettinger, Julie A.(2013)。Vaccine hesitancy: an overview。Human Vaccines & Immunotherapeutics，9(8)，1763-1773。 | | 4. | Salmon, D. A.、Dudley, M. Z.、Glanz, J. M.、Omer, S. B.(2015)。Vaccine hesitancy: causes, consequences, and a call to action。Vaccine，33(4)，D66-D71。 | | 5. | Park, H. K.、Ham, J. H.、Jang, D. H.、Lee, J. Y.、Jang, W. M.(2021)。Political ideologies, government trust, and COVID-19 vaccine hesitancy in South Korea: across-sectional survey。Int J Environ Res Public Health，18。 | | 6. | Muric, G.、Wu, Y.、Ferrara, E.(2021)。COVID-19 vaccine hesitancy on social media: building a public twitter data set of antivaccine content, vaccine misinformation, and conspiracies。JMIR Public Health Surveill，7。 | | 7. | Greenberg, J.、Dubé, E.、Driedger, M.(2017)。Vaccine hesitancy: in search of the risk communication comfort zone。PLoS Curr，9。 | | 8. | Nihlén, Fahlquist J.(2018)。Vaccine hesitancy and trust. Ethical aspects of risk communication。Scand J Public Health，46(2)，182-188。 | | 9. | Smith, M.(2015)。Vaccine safety: medical contraindications, myths, and risk communication。Pediatr Rev，36，227-238。 | | 10. | Dubé, E.、MacDonald, N. E.(2020)。How can a global pandemic affect vaccine hesitancy?。Expert Review of Vaccines，19(10)，899-901。 | | 11. | Warren, G. W.、Lofstedt, R.(2021)。COVID-19 vaccine rollout risk communication strategies in Europe: a rapid response。J Risk Res，24，369-379。 | | 12. | Cho, S. I.、Yoon, S.、Lee, H. J.(2021)。Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance database。Sci Rep，11。 | | 13. | Hacker, K. A.、Briss, P. A.、Richardson, L.、Wright, J.、Petersen, R.(2021)。COVID-19 and chronic disease: the impact now and in the future。Preventing Chronic Disease，18。 | | 14. | Yanez, N. D.、Weiss, N. S.、Romand, J. A.、Treggiari, M. M.(2020)。COVID-19 mortality risk for older men and women。BMC Public Health，20(1)，(1742)1-(1742)7。 | | 15. | Yates, T.、Zaccardi, F.、Islam, N.(2021)。Obesity, chronic disease, age, and in-hospital mortality in patients with COVID-19: analysis of ISARIC clinical characterisation protocol UK cohort。BMC Infect Dis，21。 | | 16. | Beebe, J.(1995)。Basic concepts and techniques of rapid appraisal。Hum Organ，54，42-51。 | | 17. | Vindrola-Padros, Cecilia、Chisnall, Georgia、Cooper, Silvie、Dowrick, Anna、Djellouli, Nehla、Symmons, Sophie Mulcahy、Martin, Sam、Singleton, Georgina、Vanderslott, Samantha、Vera, Norha、Johnso, Ginger A.(2020)。Carrying out rapid qualitative research during a pandemic: emerging lessons from COVID-19。Qualitative Health Research，30(14)，2192-2204。 | | 18. | Michelle, Driedger S.、Maier, R.、Jardine, C.(2021)。'Damned if you do, and damned if you don't': communicating about uncertainty and evolving science during the H1N1 influenza pandemic。J Risk Res，24，574-592。 | | 19. | Tsai, Feng-Jen、Yang, Hsiu-Wen、Lin, Chia-Ping、Liu, Jeffrey Zen(2021)。Acceptability of COVID-19 vaccines and protective behavior among adults in Taiwan: associations between risk perception and willingness to vaccinate against COVID-19。International Journal of Environmental Research and Public Health，18(11)。 | | 20. | Leask, J.、Carlson, S. J.、Attwell, K.(2021)。Communicating with patients and the public about COVID-19 vaccine safety: recommendations from the collaboration on social science and immunisation。Med J Aust，215，9-12。 | | 21. | Day, D.、Grech, L.、Nguyen, M.(2022)。Serious underlying medical conditions and covid-19 vaccine hesitancy: a large cross-sectional Analysis from Australia。Vaccines (Basel)，10。 | | 22. | Roman, I.、Andreica, I.、Baraliakos, X.、Redeker, I.、Kiltz, U.、Braun, J.(2022)。SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD。Ther Adv Musculoskelet Dis，14。 | | 23. | Wickersham, J. A.、Meyer, J. P.、Shenoi, S.(2022)。Willingness to be vaccinated against COVID-19 among people with HIV in the United States: results from a national survey。Front Med (Lausanne)，9。 | | 24. | Chia, S. C.、Lu, F.、Sun, Y.(2021)。Tracking the influence of misinformation on elderly people's perceptions and intention to accept COVID-19 vaccines。Health Commun，38(5)，855-865。 | | 25. | Freeman, R.(2009)。What Is 'Translation'?。Evid Policy，5，429-447。 | | 26. | Peretti-Watel, P.、Seror, V.、Cortaredona, S.(2020)。A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation。Lancet Infect Dis，20，769-770。 | | 27. | Chia, J. L.、Hartanto, A.(2021)。Cognitive barriers to COVID-19 vaccine uptake among older adults。Front Med (Lausanne)，8。 | | 28. | Tan, L. F.、Ang, X. Y. A.、Wei, C. J.(2021)。The challenges of vaccinating frail older adults against COVID-19 in a low-incidence country。Lancet Reg Health West Pac，12。 | | 29. | 林峻吉、官晨怡、林正揚、劉政翰、黃意婷、許銘心、陳宜萱、簡瑞琪、黃中、郭曉靜、呂芃樺、何坤霖、林尹筑、林奕任、柯咨羽、劉曉彤、戴夢凡、張書森、邱弘毅(20230400)。因應緊急公共衛生事件之快速質性研究：臺灣COVID-19疫苗猶豫調查。調查研究，50，11-59。 延伸查詢 | 研究報告| 1. | Tan, M.、Straughan, P. T.、Lim, W.、Cheong, G.(2021)。Special report on COVID-19 vaccination trends among older adults in Singapore。 | 其他| 1. | WHO。Essential programme on immunization，https://www.who.int/teams/immunization-vaccines-and-biologicals/essentialprogramme-on-immunization/demand。 | | 2. | Organization for Economic Cooperation and Development。Enhancing public trust in COVID-19 vaccination: the role of governments，https://www.oecd.org/coronavirus/policy-responses/enhancing-public-trust-in-covid-19-vaccination-the-role-of-governments-eae0ec5a/。 | | 3. | 官晨怡，邱弘毅，張書森。臺灣新冠疫苗民眾決策態度之快速質性研究調查報告，http://coph.ntu.edu.tw/web/news/news_in.jsp?np_no=NP1643141966480&lang=tw。 延伸查詢 | | 4. | 林慧淳(20210619)。接種AZ疫苗後猝死4天超過40人醫揭疫苗2大相關死因，https://www.commonhealth.com.tw/article/84448。 延伸查詢 | | 5. | (20200514)。挪威不再用AZ疫苗 現有庫存可能會捐給其他國家，https://ec.ltn.com.tw/article/breakingnews/3532232。 延伸查詢 | | 6. | 鄭郁蓁(20210407)。歐盟藥管局認AZ疫苗和血栓有關 指揮中心：繼續打，https://www.chinatimes.com/realtimenews/20210。 延伸查詢 | | 7. | 張皓翔，郭亭亞，吳璨宇(20220508)。COVID-19疫苗知識就是力量，https://docs.google.com/document/d/e/2PACX-1vRonbj6D3bX0UU1mTTjQO8u5iynhDUg-8d0Rf8qnKcNCS5o3sirFqF6fSh6Jc5YKYyNFNi9jRhpw3VD/pub。 延伸查詢 | | 8. | Stevenson, A.，Ramzy, A.(20220225)。'I Don't Dare Get the Shot': virus ravages unvaccinated older Hong Kongers，https://www.nytimes.com/2022/02/25/business/hong-kong-unvaccinated-elderly.html。 | | 9. | The Public Health Agency of Canada。COVID-19 vaccination in Canada，https://healthinfobase.canada.ca/covid-19/vaccination-coverage/。 | | 10. | 日本放送協會。日本国内のワクチン接種状況，https://www3.nhk.or.jp/news/special/coronavirus/vaccine/progress/。 延伸查詢 | | 11. | Korea Disease Control and Prevention Agency, KDCA。COVID-19 vaccination status，https://www.korea.kr/news/pressReleaseView.do?newsId=156498937。 | | 12. | 香港特別行政區政府衛生署衛生防護中心。香港新冠疫苗接種資料概覽，https://www.covidvaccine.gov.hk/zh-HK/dashboard。 延伸查詢 | | 13. | 追臺灣最新疫情 看即時數據圖表，https://topic.udn.com/event/COVID19_Taiwan。 延伸查詢 | | 14. | 張雄風(20210616)。染疫致死率近期大增 陳建仁：本土感染多中老年人是主因，https://www.cna.com.tw/news/firstnews/202106160035.aspx。 延伸查詢 | | 15. | (20210614)。如何降低死亡率？醫：這3種人優先打疫苗，https://health.ltn.com.tw/article/breakingnews/3569335。 延伸查詢 | | 16. | Ministry of Health (Singapore)。Primary series vaccination take up by age group (completed full regimen)，https://www.moh.gov.sg/covid-19/vaccination/statistics。 | |
| |